The global CRISPR technology market is entering a high-growth phase, underpinned by gene-editing breakthroughs, precision medicine, and strong public–private investment. Valued at around USD 3.6 billion in 2025 and projected to reach nearly USD 8.0 billion by 2033, the market is expected to grow at a CAGR of about 10.8% over 2025–2033.​ Browse Detailed Summary of Research...